Shanghai Haixin Group Co., Ltd. (SHA:600851)

China · Delayed Price · Currency is CNY

8.57

-0.21 (-2.39%)

Jul 13, 2026, 3:00 PM CST

20.70% (1Y)

Market Cap	7.30B +19.4%
Revenue (ttm)	705.50M -10.6%
Net Income	171.91M +13.3%
EPS	0.14 +13.3%
Shares Out	1.21B
PE Ratio	61.66
Forward PE	n/a
Dividend	0.05 (0.57%)
Ex-Dividend Date	Jul 29, 2025

Volume	22,089,900
Open	8.76
Previous Close	8.78
Day's Range	8.57 - 9.00
52-Week Range	6.40 - 10.69
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Shanghai Haixin Group

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shanghai Haixin Group Co., Ltd. was founded in 1986 and is headquartered in S... [Read more]

Industry Conglomerates

Sector Industrials

Founded 1986

Employees 675

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600851

Full Company Profile

Financial Performance

In 2025, Shanghai Haixin Group's revenue was 757.52 million, a decrease of -4.82% compared to the previous year's 795.88 million. Earnings were 176.00 million, an increase of 16.60%.

Financial Statements